Influence of a Serratia marcescens outbreak on the gut microbiota establishment process in low-weight preterm neonates

PLoS One. 2019 May 21;14(5):e0216581. doi: 10.1371/journal.pone.0216581. eCollection 2019.

Abstract

Adequate gut microbiota establishment is important for lifelong health. The aim was to sequentially analyze the gut microbiota establishment in low-birth-weight preterm neonates admitted to a single neonatal intensive care unit during their first 3 weeks of life, comparing two epidemiological scenarios. Seven control infants were recruited, and another 12 during a severe S. marcescens outbreak. Meconium and feces from days 7, 14, and 21 of life were collected. Gut microbiota composition was determined by 16S rDNA massive sequencing. Cultivable isolates were genotyped by pulsed-field gel electrophoresis, with four S. marcescens submitted for whole-genome sequencing. The expected bacterial ecosystem expansion after birth is delayed, possibly related to antibiotic exposure. The Proteobacteria phylum dominates, although with marked interindividual variability. The outbreak group considerably differed from the control group, with higher densities of Escherichia coli and Serratia to the detriment of Enterococcus and other Firmicutes. Curiously, obligate predators were only detected in meconium and at very low concentrations. Genotyping of cultivable bacteria demonstrated the high bacterial horizontal transmission rate that was confirmed with whole-genome sequencing for S. marcescens. Preterm infants admitted at NICU are initially colonized by homogeneous microbial communities, most of them from the nosocomial environment, which subsequently evolve according to the individual conditions. Our results demonstrate the hospital epidemiology pressure, particularly during outbreak situations, on the gut microbiota establishing process.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cross Infection / microbiology*
  • DNA, Bacterial / genetics
  • DNA, Bacterial / isolation & purification
  • DNA, Ribosomal / genetics
  • Disease Outbreaks*
  • Feces / microbiology*
  • Female
  • Gastrointestinal Microbiome / genetics*
  • Humans
  • Infant
  • Infant, Low Birth Weight / metabolism*
  • Infant, Newborn
  • Infant, Premature / metabolism*
  • Intensive Care Units, Neonatal
  • Male
  • Serratia Infections / microbiology*
  • Serratia marcescens / genetics
  • Serratia marcescens / growth & development
  • Serratia marcescens / isolation & purification

Substances

  • DNA, Bacterial
  • DNA, Ribosomal

Grants and funding

Claudio Alba was supported by “Consejería de Educación, Juventud y Deporte de la Comunidad de Madrid” and European Social Funds. Claudia Saralegui was supported by “Fundación Mutua Madrileña” grant to Rosa del Campo achieved in 2017 call with reference number AP165902017.